Correction concern figures and figures captions of original paper [1]:
1. Current Figure one is actually Figure 3 and the caption should be:
Anzeige
Figure 3 Expression of AdipoR1 protein in the anterior and posterior pituitary. A comparison of the expression levels of adiponectin receptor 1 (AdipoR1) protein determined by Western blotting analysis in porcine anterior (A) and posterior (B) pituitary glands between days 2–3, 10–12, 14–16 and 17–19 of the oestrous cycle, and (C) between anterior (AP) and posterior (NP) pituitary glands on days 2–3, 10–12, 14–16 and 17–19 of the cycle. Upper panels: representative immunoblots (MM, molecular marker; SM, skeletal muscles – positive control); lower panels: densitometric analysis of adiponectin receptor 1 protein relative to actin protein. Values are expressed as means ± S.E.M. in arbitrary optical density units (n = 5). Bars with different superscripts are significantly different. Capital letters indicate p < 0.05; ***p < 0.001.
Instead of:
Expression of AdipoR1 mRNA in the anterior and posterior pituitary. Comparison of adiponectin receptor 1 (AdipoR1) mRNA expression determined by quantitative real-time PCR in porcine anterior (A) and posterior (B) pituitary glands between days 2–3, 10–12, 14–16 and 17–19 of the oestrous cycle, and (C) between anterior and posterior pituitary glands on days 2–3, 10–12, 14–16 and 17–19 of the cycle. Results are means ± S.E.M. (n = 5). Bars with different superscripts are significantly different. Capital letters indicate p < 0.05; **p < 0.01; ***p < 0.001.
2. Current Figure two is actually Figure 4 and the caption should be:
Anzeige
Figure 4 Expression of AdipoR2 protein in the anterior and posterior pituitary. Comparison of adiponectin receptor 2 (AdipoR2) protein expression determined by Western blotting analysis in porcine anterior (A) and posterior (B) pituitary glands between days 2–3, 10–12, 14–16 and 17–19 of the oestrous cycle, and (C) between anterior and posterior pituitary glands on days 2–3, 10–12, 14–16 and 17–19 of the cycle. Upper panels: representative immunoblots (MM, molecular marker; L, liver – positive control); lower panels: densitometric analysis of adiponectin receptor 2 protein relative to actin protein. Values are expressed as means ± S.E.M. in arbitrary optical density units (n = 5). Bars with different superscripts are significantly different. Capital letters indicate p < 0.05;**p < 0.01; ***p < 0.001.
Instead of:
Expression of AdipoR2 mRNA in the anterior and posterior pituitary. Comparison of adiponectin receptor 2 (AdipoR2) mRNA expression determined by quantitative real-time PCR in porcine anterior (A) and posterior (B) pituitary glands between days 2–3, 10–12, 14–16 and 17–19 of the oestrous cycle, and (C) between anterior and posterior pituitary glands on days 2–3, 10–12, 14–16 and 17–19 of the cycle. Results are means ± S.E.M. (n = 5). Bars with different superscripts are significantly different. Capital letters indicate p < 0.05; **p < 0.01; ***p < 0.001.
3. Current Figure three is actually Figure 1 and the caption should be:
Figure 1 Expression of AdipoR1 mRNA in the anterior and posterior pituitary. Comparison of adiponectin receptor 1 (AdipoR1) mRNA expression determined by quantitative real-time PCR in porcine anterior (A) and posterior (B) pituitary glands between days 2–3, 10–12, 14–16 and 17–19 of the oestrous cycle, and (C) between anterior and posterior pituitary glands on days 2–3, 10–12, 14–16 and 17–19 of the cycle. Results are means ± S.E.M. (n = 5). Bars with different superscripts are significantly different. Capital letters indicate p < 0.05; **p < 0.01; ***p < 0.001.
×
×
×
Instead of:
Expression of AdipoR1 protein in the anterior and posterior pituitary. A comparison of the expression levels of adiponectin receptor 1 (AdipoR1) protein determined by Western blotting analysis in porcine anterior (A) and posterior (B) pituitary glands between days 2–3, 10–12, 14–16 and 17–19 of the oestrous cycle, and (C) between anterior (AP) and posterior (NP) pituitary glands on days 2–3, 10–12, 14–16 and 17–19 of the cycle. Upper panels: representative immunoblots (MM, molecular marker; SM, skeletal muscles-positive control); lower panels: densitometric analysis of adiponectin receptor 1 protein relative to actin protein. Values are expressed as means ± S.E.M. in arbitrary optical density units (n = 5). Bars with different superscripts are significantly different. Capital letters indicate p < 0.05; ***p < 0.001.
4. Current Figure four is actually Figure 2 and the caption should be:
Anzeige
Figure 2 Expression of AdipoR2 mRNA in the anterior and posterior pituitary. Comparison of adiponectin receptor 2 (AdipoR2) mRNA expression determined by quantitative real-time PCR in porcine anterior (A) and posterior (B) pituitary glands between days 2–3, 10–12, 14–16 and 17–19 of the oestrous cycle, and (C) between anterior and posterior pituitary glands on days 2–3, 10–12, 14–16 and 17–19 of the cycle. Results are means ± S.E.M. (n = 5). Bars with different superscripts are significantly different. Capital letters indicate p < 0.05; **p < 0.01; ***p < 0.001.
×
Instead of:
Expression of AdipoR2 mRNA in the anterior and posterior pituitary. Comparison of adiponectin receptor 2 (AdipoR2) protein expression determined by Western blotting analysis in porcine anterior (A) and posterior (B) pituitary glands between days 2–3, 10–12, 14–16 and 17–19 of the oestrous cycle, and (C) between anterior and posterior pituitary glands on days 2–3, 10–12, 14–16 and 17–19 of the cycle. Upper panels: representative immunoblots (MM, molecular marker; L, liver-positive control); lower panels: densitometric analysis of adiponectin receptor 2 protein relative to actin protein. Values are expressed as means ± S.E.M. in arbitrary optical density units (n = 5). Bars with different superscripts are significantly different. Capital letters indicate p < 0.05; **p < 0.01; ***p < 0.001.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.
Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.
Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.
Update Gynäkologie
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.